Medical Implants Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Orthopedic, Cardiovascular, Spinal, Ophthalmic, Dental, Facial, Others), By Material (Metals And Alloys, Ceramic, Polymers, Natural), And By Geography - Forecasts From 2023 To 2028

  • Published : Jan 2023
  • Report Code : KSI061610364
  • Pages : 155

Medical implants are efficient in enhancing the existing biological structure while replacing the damaged one. Screws, orthopedic rods, and pins are examples of implantable devices which are efficiently used in repairing artificial hip joints to replace the hip bones that are worn by arthritis, and fractured bones among others. Medical implants are imperatively used in areas such as orthopedic, cardiovascular, neurological, and even dental ailments. It is also important to note that these implants are made up of bones, skin tissues, and even from skin whereas there are implants that are made up of plastic or ceramic materials including metal. These implants can be used permanently as well as they can be removed when they are no longer required. The increasing number of road accidents followed by the growing geriatric population are a few factors that are driving the demand for the medical implants market worldwide. Moreover, the presence of chronic disease is further fuelling the demand for this market. Further, the increasing awareness about the use of medical plants along with the benefits they offer will furthermore create a demand for these in the market amongst healthcare professionals.

The medical implant market is expected to surge in the coming years due to the rise in chronic diseases and the increasing aging population.

The immunity levels start to decrease as individuals grow out of their age which makes them susceptible to multiple diseases and problems.  These diseases can vary from cardiovascular ones, orthopedic problems due to weakness in the bones, dental disorders, and many more. In this regard, the medical implant market in the increasingly aged population plays an imperative role. Further, tooth loss is the most common issue which is found with the increasing aging population and this particular factor is expected to drive the market growth of the medical implant market. For instance, according to the American Academy of Implant Dentistry (AAID), the United States is said to consist of about 3 million individuals who are currently having dental implants and in recent times, this number is expected to grow tremendously by 500,000 annually.

Key Developments

  • In March 2022, Bredent Medical's whiteSKY ceramic implant system added a new one-piece whiteSky Tissue Line, which is adaptable and appropriate for a variety of indications, including single restorations in the aesthetic zone and short-span bridges in the premolar and molar area.
  • In April 2022, Neodent, a well-known provider of dental implants in Brazil and a member of the Straumann Group, unveiled a brand-new implant system. The brand-new item, called Zi, is made of zirconia, which is renowned for its exceptional strength and beauty. Zi's global premiere was commemorated at a virtual event that drew 1,600 viewers from 92 different nations.
  • ZimVie Inc, in June 2022, announced that the FDA (Food and Drug Administration) of the US had cleared the T3 PRO Tapered Implant and Encode Emergence Healing Abutment in the country, which was the latest addition to ZimVie’s product portfolio of dental implants and was an upgrade to the T3 Tapered Implant.
  • In February 2022, DeGen Medical, Inc., which is a form dealing with spinal implants and specializing in augmented reality, launched the Impulse AM, which is a 3D-printed porous titanium implant for posterior interbody fusion.

By materials, the medical implants market is segmented into metals and alloys, ceramics, polymers, and natural. Ceramics as a biomaterial in the medical implants market will witness a rise in demand during the forecast period. Ceramics are incredibly durable and can withstand intense pressure, nuclear radiation, highly corrosive chemicals, and high temperatures. The above factors mentioned of ceramic material make them the perfect choice for a wide range of medical implant applications, including implanted electrical sensors, stimulators, and drug delivery systems.

Regional Insights

Based on geography, the medical implants market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. The North American region is estimated to hold a significant market share due to the advanced medical and healthcare facilities in the region along with the relatively high disposable income of the people. According to data by the Centres for Disease Control and Prevention in 2021, about 1 in 5 people aged 65 and above in the US had complete tooth loss. Segmenting it further, 13% of seniors aged from 65 to 74 and 26% of seniors aged 75 and above had undergone complete tooth loss. Tooth decay is a cause of this in multiple cases. Further, according to data from the American Dental Association in 2020, 91% of adults in the US aged between 20 and 65 have dental cavities, and about 27% of people were reported to not have undergone any treatment for the same. 

Medical Implants Market Scope:


Report Metric Details
 Growth Rate  CAGR during the forecast period
 Base Year  2021
 Forecast Period  2023–2028
 Forecast Unit (Value)  USD Billion
 Segments Covered  Type, Material, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered Johnson & Johnson Services, Inc., Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Conmed Corporation, Globus Medical, Inc., Integra Lifesciences Holdings Corporation, Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet
 Customization Scope  Free report customization with purchase


Market Segmentation:

  • By Type
    • Orthopedic
    • Cardiovascular
    • Spinal
    • Ophthalmic
    • Dental
    • Facial
    • Others
  • By Material    
    • Metals And Alloys
    • Ceramic
    • Polymers
    • Natural
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • The Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others


1.1. Market Definition

1.2. Market Segmentation



2.1. Research Data

2.2. Assumptions



3.1. Research Highlights



4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis



5.1. Introduction

5.2. Orthopedic

5.3. Cardiovascular

5.4. Spinal

5.5. Ophthalmic

5.6. Dental

5.7. Facial

5.8. Others



6.1. Introduction

6.2. Metals And Alloys

6.3. Ceramic

6.4. Polymers

6.5. Natural



7.1. Introduction

7.2. North America

7.2.1. United States

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. United Kingdom

7.4.2. Germany

7.4.3. France

7.4.4. Spain

7.4.5. Others

7.5. The Middle East and Africa

7.5.1. Saudi Arabia

7.5.2. UAE

7.5.3. Israel

7.5.4. Others

7.6. Asia Pacific

7.6.1. Japan

7.6.2. China

7.6.3. India

7.6.4. South Korea

7.6.5. Indonesia

7.6.6. Thailand

7.6.7. Others



8.1 Major Players and Strategy Analysis

8.2 Emerging Players and Market Lucrativeness

8.3 Mergers, Acquisitions, Agreements, and Collaborations

8.4 Vendor Competitiveness Matrix



9.1 Johnson & Johnson Services, Inc.

9.2 Abbott Laboratories

9.3 Boston Scientific Corporation

9.4 Cardinal Health, Inc.

9.5 Conmed Corporation

9.6 Globus Medical, Inc.

9.7 Integra Lifesciences Holdings Corporation

9.8 Smith & Nephew PLC

9.9 Stryker Corporation

9.10 Zimmer Biomet

Johnson & Johnson Services, Inc.

Abbott Laboratories

Boston Scientific Corporation

Cardinal Health, Inc.

Conmed Corporation

Globus Medical, Inc.

Integra Lifesciences Holdings Corporation

Smith & Nephew PLC

Stryker Corporation

Zimmer Biomet